NM_001563.4:c.2324G>C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001563.4(IMPG1):āc.2324G>Cā(p.Ser775Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000868 in 1,151,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001563.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IMPG1 | NM_001563.4 | c.2324G>C | p.Ser775Thr | missense_variant | Exon 17 of 17 | ENST00000369950.8 | NP_001554.2 | |
IMPG1 | NM_001282368.2 | c.2090G>C | p.Ser697Thr | missense_variant | Exon 16 of 16 | NP_001269297.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IMPG1 | ENST00000369950.8 | c.2324G>C | p.Ser775Thr | missense_variant | Exon 17 of 17 | 1 | NM_001563.4 | ENSP00000358966.3 | ||
IMPG1 | ENST00000611179.4 | c.2090G>C | p.Ser697Thr | missense_variant | Exon 16 of 16 | 5 | ENSP00000481913.1 | |||
IMPG1 | ENST00000369952.3 | c.407G>C | p.Ser136Thr | missense_variant | Exon 4 of 4 | 3 | ENSP00000358968.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 8.68e-7 AC: 1AN: 1151756Hom.: 0 Cov.: 16 AF XY: 0.00 AC XY: 0AN XY: 582360
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.